Mystery Brain Disease in New Brunswick May Not Have Been a Mystery After All
Study sheds light on cluster of Canadians with symptoms that appeared to resemble prion disease
Related Articles
GLP-1 Drugs and Liver Screening Took Center Stage at AACE Meeting
Obesity, diabetes, and metabolic liver disease dominate annual meeting talks
GLP-1 Drugs May Help in Fibromyalgia, Large Records Study Suggests
TikTok points researcher toward signal of benefit
Autistic Doctors Weigh In on ‘Love on the Spectrum’
They praise the show’s warmth, but say it still misses most of the spectrum
Ultraprocessed Foods Raised Lupus Risk at Least 50% in Women
Higher intake of ultraprocessed foods among women was associated with a >50% higher risk for systemic lupus erythematosus (SLE). That’s the key finding in a…
Anti-Vaxxers on CDC Panel: A Broken Promise From RFK Jr.?
Being called an anti-vaxxer is a compliment, one new ACIP member says
Polypill Approved for Hypertension, Including as Initial Therapy
The pill comes in three doses and contains telmisartan, amlodipine, and indapamide
Surgical Blood Conservation Technique Falls Short in Trial
Red cell transfusion rates, patient outcomes unchanged with acute normovolemic hemodilution
Zap the Skull to Treat Rheumatoid Arthritis Pain?
Electrical stimulation found effective in small randomized trial
Managing IBD Patients Who Don’t Respond, or Can’t Tolerate, Upadacitinib
Upadacitinib (Rinvoq), a selective Janus kinase 1 (JAK1) inhibitor, is an emerging treatment for inflammatory bowel disease (IBD) and is increasingly used in clinical practice.…
Good News, Mostly, on Preventing Rheumatoid Arthritis
Long-term results could affect practice for at least some patients